Ecosystem allies

Strategic partnerships accelerating your path to the clinic

Antibody Platforms

Building the most efficient companies with a unique venture approach

Creating asset centric drug companies with incredible capital efficiency by leveraging the platforms and services of Alloy Therapeutics.

Ecosystem allies uniting to advance drug discovery from concept to clinic

Advance the development of your discovered drugs

Wheeler Bio’s modular CMC approach accelerates the transition from discovery to IND. Under Wheeler’s PhaseTM offering, Alloy partners can receive preferred services including a seamless transition from discovery to IND, reduced initial payment, and dollar-for-dollar reductions in Alloy commercial milestones.

Accelerate to the clinic with strategic research support

We work with a number of organizations that can help you through the clinic by acting as a strategic leader to drive timelines, streamline handoffs, and oversee RFPs. Starting this early is critical to the success of a discovered drug ensuring that lead candidates are optimized for the clinic.

Become part of the ecosystem

Name(Required)

Email(Required)

Company(Required)

Country(Required)

Comments(Required)

By clicking submit you consent to receive email communications about Alloy Therapeutics products and services and agree to our Terms. Your data will be processed in accordance with our Privacy Policy. You may opt out at any time.